Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Published in: Angiogenesis 1/2004

01-03-2004

Angiogenesis Inhibition by Angiostatin, Endostatin and TNP-470 Prevents Cyclophosphamide Induced Cystitis

Authors: Wolf-Dietrich Beecken, Tobias Engl, Roman Blaheta, Wassilios Bentas, Eike-Gerd Achilles, Dietger Jonas, Yuen Shing, Kevin Camphausen

Published in: Angiogenesis | Issue 1/2004

Login to get access
Metadata
Title
Angiogenesis Inhibition by Angiostatin, Endostatin and TNP-470 Prevents Cyclophosphamide Induced Cystitis
Authors
Wolf-Dietrich Beecken
Tobias Engl
Roman Blaheta
Wassilios Bentas
Eike-Gerd Achilles
Dietger Jonas
Yuen Shing
Kevin Camphausen
Publication date
01-03-2004
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 1/2004
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1023/B:AGEN.0000037334.70257.d2

Other articles of this Issue 1/2004

Angiogenesis 1/2004 Go to the issue

OriginalPaper

Activated Neu/ErbB-2 Induces Expression of the Vascular Endothelial Growth Factor Gene by Functional Activation of the Transcription Factor Sp 1

Instructions for Authors

Instructions for Authors

OriginalPaper

Inhibition of Angiogenesis by Aβ Peptides

OriginalPaper

Different Mechanisms Lead to the Angiogenic Process Induced by Three Adenocarcinoma Cell Lines

OriginalPaper

Quantitative Angiogenesis Assays in vivo – A Review

OriginalPaper

Eph Receptor Tyrosine Kinases in Angiogenesis: From Development to Disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits